WO2025008787 - SOLID FORMS OF MITAPIVAT HEMISULFATE
National phase entry is expected:
Publication Number
WO/2025/008787
Publication Date
09.01.2025
International Application No.
PCT/IB2024/056546
International Filing Date
04.07.2024
Title **
[English]
SOLID FORMS OF MITAPIVAT HEMISULFATE
[French]
FORMES SOLIDES D'HÉMISULFATE DE MITAPIVAT
Applicants **
BIOPHORE INDIA PHARMACEUTICALS PVT. LTD
Inventors
PULLAGURLA, Manik Reddy
KOTHAKONDA, Kiran Kumar
PITTA, Bhaskar Reddy
BOGE, Rajesham
RANGISETTY, Jagadeesh Babu
Priority Data
202341044973
05.07.2023
IN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
IP India
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 1954 | |
| EPO | Filing, Examination, Granting | 11600 | |
| Japan | Filing, Examination, Granting | 2025 | |
| South Korea | Filing, Examination, Granting | 1783 | |
| USA | Filing, Examination, Granting | 7740 |
Total:
25,102
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present invention relates to crystalline form of Mitapivat hemisulfate (1). The present invention further relates to a process for preparing crystalline form of Mitapivat hemisulfate (1) and pharmaceutical compositions thereof. The crystalline form of Mitapivat hemisulfate (1) has been characterized by X-Ray powder diffractogram, Differential scanning Calorimetry and Thermogravimetric analysis.[French]
La présente invention concerne une forme cristalline d'hémisulfate de mitapivat (1). La présente invention concerne en outre un procédé de préparation de forme cristalline d'hémisulfate de mitapivat (1) et des compositions pharmaceutiques associées. La forme cristalline de l'hémisulfate de mitapivat (1) a été caractérisée par un diffractogramme de rayons X sur poudre, une analyse calorimétrique différentielle et une analyse thermogravimétrique.